Vanguard Group’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.9M | Buy |
3,266,999
+395,386
| +14% | +$1.68M | ﹤0.01% | 2737 |
|
|
2025
Q1 | $10.8M | Buy |
2,871,613
+186,604
| +7% | +$702K | ﹤0.01% | 2806 |
|
|
2024
Q4 | $15.7M | Buy |
2,685,009
+152,117
| +6% | +$887K | ﹤0.01% | 2708 |
|
|
2024
Q3 | $30.2M | Sell |
2,532,892
-209,772
| -8% | -$2.5M | ﹤0.01% | 2398 |
|
|
2024
Q2 | $29.7M | Buy |
2,742,664
+334,976
| +14% | +$3.62M | ﹤0.01% | 2368 |
|
|
2024
Q1 | $27.3M | Sell |
2,407,688
-298,207
| -11% | -$3.38M | ﹤0.01% | 2444 |
|
|
2023
Q4 | $38M | Buy |
2,705,895
+995,588
| +58% | +$14M | ﹤0.01% | 2302 |
|
|
2023
Q3 | $21.1M | Buy |
1,710,307
+36,785
| +2% | +$454K | ﹤0.01% | 2529 |
|
|
2023
Q2 | $15.1M | Buy |
1,673,522
+165,755
| +11% | +$1.5M | ﹤0.01% | 2715 |
|
|
2023
Q1 | $5.23M | Buy |
1,507,767
+32,417
| +2% | +$112K | ﹤0.01% | 3289 |
|
|
2022
Q4 | $3.61M | Buy |
1,475,350
+721
| +0% | +$1.77K | ﹤0.01% | 3445 |
|
|
2022
Q3 | $4.07M | Buy |
1,474,629
+61,160
| +4% | +$169K | ﹤0.01% | 3424 |
|
|
2022
Q2 | $5.75M | Buy |
1,413,469
+26,274
| +2% | +$107K | ﹤0.01% | 3299 |
|
|
2022
Q1 | $5.91M | Sell |
1,387,195
-761,858
| -35% | -$3.25M | ﹤0.01% | 3451 |
|
|
2021
Q4 | $20.1M | Sell |
2,149,053
-592,978
| -22% | -$5.55M | ﹤0.01% | 2838 |
|
|
2021
Q3 | $75.6M | Buy |
2,742,031
+279,776
| +11% | +$7.71M | ﹤0.01% | 2145 |
|
|
2021
Q2 | $68.9M | Buy |
2,462,255
+1,536,117
| +166% | +$43M | ﹤0.01% | 2198 |
|
|
2021
Q1 | $30.7M | Buy |
926,138
+122,441
| +15% | +$4.06M | ﹤0.01% | 2580 |
|
|
2020
Q4 | $38.6M | Buy |
+803,697
| New | +$38.6M | ﹤0.01% | 2330 |
|